FundingPayments

Correlia Biosystems: Raises $7M in Series A Funding

  • Correlia Biosystems, a Berkeley, CA-based life science startup, closed a $7m Series A financing round
  • The round led by Neotribe Ventures, joined by Cota Capital, the Regents of the University of California, and others
  • NeoTribe Ventures joins Correlia’s board of directors as part of the financing
  • The company also intends to use the funds for the commercial launch of its immunoassay platform
  • This will also the first instrument planned in their larger suite of proteomics tools focused on highly efficient and automated protein measurements
  • Correlia is launching a product to miniaturize Elisa, a quantitative test for proteins and antibodies widely used in drug development, vaccine development, and diagnostics
Previous article
Shinhan Bank: Enhanced Cooperations with partners in diversified fields
Next article
Alliance Data: Completes Acquisition of Bread
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

Revolut Strengthens Presence with Indian Hiring Spree

The financial technology company seeks to expand its team in India.Highlights: Revolut is launching a significant hiring campaign...
FinTech

Visa Strengthens Subscription Management Service for Businesses

New solutions aim to simplify recurring payment management for companies.Highlights: Visa has launched a new subscription management service.The...
FinTech

Mastercard to Sell Nets Payments Unit Following $3.2 Billion Acquisition

The divestment follows Mastercard's strategic review of its portfolio.Highlights: Mastercard is set to sell its Nets payments unit.The...
FinTech

Mastercard Seeks to Offload Payments Unit It Acquired for $32 Billion

The proposed sale comes as Mastercard re-evaluates its payments strategy.Highlights: Mastercard aims to sell its payments unit, originally...